PKBDO2121FRGI
PKBDO2121FRGI
released
Clinical summary
Diabetes status
Control Without Diabetes
BMI
31
HbA1c %
5
C-Peptide (ng/ml)
—
Diabetes duration
—
Demographics
- Age (y)
- 25
- Gender
- Male
- Genetic Sex
- Male
- Ethnicity
- White
- Predicted genetic ancestry
- European (100%)
Additional clinical
- Diabetes (ontology)
- No ontology term
- T1D stage
- No sufficient information to derive
- Derived diabetes status
- Normal
- Living donor
- No
- Cause of death
- Anoxia
- Hospital stay (h)
- 96
HLA typing
Status: X/X
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 2 | 29 | OPO |
| B | 7 | 45 | OPO |
| C | 6 | 7 | OPO |
| Bw4 | 0 | — | OPO |
| Bw6 | 1 | — | OPO |
| DR | 15 | 16 | OPO |
| DR51 | 1 | — | OPO |
| DR52 | 0 | — | OPO |
| DR53 | 0 | — | OPO |
| DQ | 5 | 6 | OPO |
Data available
Islet
scRNAseqAccess dataset
Supplementary
IIDP
IIDP:SAMN10079665
- Pancreas tissue available
- No
- Other tissues
- —
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
